Related Experiment Video
Updated: May 26, 2026

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
Published on: May 20, 2020
Insights into the conformational switching mechanism of the human vascular endothelial growth factor receptor type 2
Matteo Chioccioli1, Simone Marsili, Claudia Bonaccini
1Laboratory of Molecular Modeling Cheminformatics and QSAR, Department of Pharmaceutical Sciences, University of Firenze, Via Ugo Schiff 6, I-50019 Sesto Fiorentino, Firenze Italy.
Abstract:
Human vascular endothelial growth factor receptor type 2 (h-VEFGR2) is a receptor tyrosine kinase involved in the angiogenesis process and regarded as an interesting target for the design of anticancer drugs. Its activation/inactivation mechanism is related to conformational changes in its cytoplasmatic kinase domain, involving first among all the αC-helix in N-lobe and the A-loop in C-lobe. Affinity of inhibitors for the active or inactive kinase form could dictate the open or closed conformation of the A-loop, thus making the different conformations of the kinase domain receptor (KDR) domain different drug targets in drug discovery. In this view, a detailed knowledge of the conformational landscape of KDR domain is of central relevance to rationalize the efficiency and selectivity of kinase inhibitors. Here, molecular dynamics simulations were used to gain insight into the conformational switching activity of the KDR domain and to identify intermediate conformations between the two limiting active and inactive conformations. Specific energy barriers have been selectively removed to induce, and hence highlight at the atomistic level, the regulation mechanism of the A-loop opening. The proposed strategy allowed to repeatedly observe the escape of the KDR domain from the DFG-out free energy basin and to identify rare intermediate conformations between the DFG-out and the DFG-in structures to be employed in a structure-based drug discovery process.
Insights
Human vascular endothelial growth factor receptor type 2 (h-VEFGR2) kinase domain undergoes conformational changes crucial for drug targeting. Molecular dynamics simulations reveal intermediate states, aiding the design of selective anticancer drugs.
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- Human vascular endothelial growth factor receptor type 2 (h-VEFGR2) is a key regulator of angiogenesis and a significant target for anticancer drug development.
- The receptor's kinase domain undergoes conformational changes, particularly involving the αC-helix and A-loop, which are critical for its activation and inactivation.
- Understanding these conformational dynamics is essential for designing selective kinase inhibitors.
Purpose of the Study:
- To investigate the conformational landscape of the kinase domain receptor (KDR) domain using molecular dynamics simulations.
- To identify intermediate conformations between the active (DFG-in) and inactive (DFG-out) states.
- To elucidate the atomistic mechanisms regulating A-loop opening and KDR domain conformational switching.
Main Methods:
- Utilized molecular dynamics simulations to explore the conformational space of the KDR domain.
- Employed targeted energy modifications to facilitate and observe the A-loop opening mechanism.
- Analyzed simulation trajectories to identify rare intermediate conformations.
Main Results:
- Successfully observed the KDR domain transitioning from the DFG-out conformation.
- Identified novel intermediate conformations between the DFG-out and DFG-in states.
- Provided atomistic insights into the regulation of the A-loop opening mechanism.
Conclusions:
- Detailed knowledge of KDR domain conformational dynamics is vital for structure-based drug discovery.
- The identified intermediate conformations represent potential new targets for enhancing inhibitor selectivity and efficacy.
- This study provides a foundation for rational drug design targeting h-VEFGR2.
Related Concept Videos
Receptor Tyrosine Kinases
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
G Protein-coupled Receptors
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Intracellular Signaling Affects Focal Adhesions
Some...
